Biotech Company Secures 44,000-SF Lease in Philadelphia

PHILADELPHIA, PA – The life science company, Biomeme has signed a 44,000-square-foot lease at Netrality Data Centers’ multi-use facility, located at 401 N. Broad St. in Philadelphia, PA.

Netrality Data Centers originally acquired the 11-story, 1.3-million-square-foot building in 2014, and has since invested more than $50 million in capital improvements at the property in effort to position and enhance the space for life science users.

As a manufacturer of portable, real-time polymerase chain reaction testing solutions, Biomeme will utilize the leased space as its new corporate headquarters and will occupy the space with lab, manufacturing and office operations.

Biomeme plans to relocate from its current space at 1015 Chestnut St. in the fall of 2021.

The new lease triples the size of Biomeme’s current space, and allows for expanded production of the company’s devices and products.

“Netrality is proud to bring Biomeme into our robust ecosystem of life science, digital health and tech-enable companies that are uncovering cutting edge solutions,” says Gerald M. Marshall, CEO of Netrality Data Centers. “As the epicenter of connectivity in Philadelphia, Netrality provides the foundational elements for life sciences and biotech companies, like Biomeme, to access mission critical infrastructure and continuous uptime as they continue advancing healthcare technology including the fight against COVID-19.”

CBRE’s Christian Dyer represented Netrality Data Centers in arranging the lease.

“Biomeme’s decision to move to 401 North Broad is a game changer for the building as we move aggressively into the life sciences arena,” states Dyer. “Their commitment to the building, along with our recent signing of the Nerd Street Gamers headquarters and LocalHost facility, solidify 401 North Broad’s position as the Philadelphia’s hub for creativity, innovation and technology.”